CEACAM5 and colorectal carcinoma: CEA is a promising plasma biomarker for the detection of CRC with high specificity and sensitivity (12, 14), however, due to the limited organ specificity (15), it is not the best sole biomarker for population-based screening, yet it might be useful in CRC recurrence monitoring (16) and metastasis (17).